Patients with DCIS receiving anastrozole reported symptoms different from those receiving tamoxifen both groups reported similar quality of life

Estrogen receptor mutations detected in plasma associated with worse overall survival in metastatic breast cancer

EU council conclusions ‘realistic’ on implementing personalised medicine

Improved survival outcomes in women with HER2-negative breast cancer after neoadjuvant chemotherapy

Breast-conserving therapy yields better 10-year outcomes than mastectomy for early-stage patients

Adding carboplatin to presurgery chemotherapy improved disease-free survival for patients with triple-negative breast cancer

Mastectomy plus reconstruction has higher complication rates and costs than lumpectomy plus radiation

Analysis of blood samples finds ESR1 gene mutations are prevalent and associated with worse overall survival

Breast-conserving therapy yielded better outcomes than mastectomy for early-stage patients

Mastectomy plus reconstruction has higher complication rates and costs than lumpectomy plus radiation

Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3B

Denosumab improves disease-free survival for postmenopausal patients with HR-positive breast cancer